Pearl Diagnostics

Pearl Diagnostics

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://pearldx.com/

Last Round

Seed Round

Apr 21, 2026

Total Funding Raised

$15.9M

Momentum Score

50 /100

Company Overview

Pearl Diagnostics is a health diagnostics company that develops novel in-vitro diagnostic tests for non-invasive detection of life-threatening lung infections.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

non-invasive diagnosticsurine-based diagnosticsaspergillosis testextracellular vesicle detectioninfectious disease diagnosticsliquid biopsydiagnostic assayELISA kitlung infection diagnosisin-vitro diagnosticsIVDEV diagnosticsmedical diagnosticsclinical laboratory testCE markFDA cleared diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pearl Diagnostics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pearl Diagnostics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Seed RoundApr 21, 2026
Series AMar 19, 2026
GrantFeb 11, 2025
SeedJul 18, 2022
GrantJul 18, 2017
Grant
Feb 1, 2015

Key People

Founding team and executive leadership

Eric Gornstein

Chief Executive Officer

Executive Team

Pearl Diagnostics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    $11.15M raised in Seed Round.

  • Apr 17, 2026

    Monthly visitors increased 79% MoM, reaching 2.5K.

Pearl Diagnostics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pearl Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pearl Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range6
Year Founded2014
Last FundingApr 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.